Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment

IMPORTANCE: The benefit of adjuvant chemotherapy after resection of pancreatic cancer following neoadjuvant combination treatment with folinic acid, fluorouracil, irinotecan, and oxaliplatin (FOLFIRINOX) is unclear. OBJECTIVE: To assess the association of adjuvant chemotherapy with overall survival...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Oncol
Main Authors: van Roessel, Stijn, van Veldhuisen, Eran, Klompmaker, Sjors, Janssen, Quisette P., Abu Hilal, Mohammed, Alseidi, Adnan, Balduzzi, Alberto, Balzano, Gianpaolo, Bassi, Claudio, Berrevoet, Frederik, Bonds, Morgan, Busch, Olivier R., Butturini, Giovanni, del Chiaro, Marco, Conlon, Kevin C., Falconi, Massimo, Frigerio, Isabella, Fusai, Giuseppe K., Gagnière, Johan, Griffin, Oonagh, Hackert, Thilo, Halimi, Asif, Klaiber, Ulla, Labori, Knut J., Malleo, Giuseppe, Marino, Marco V., Mortensen, Michael B., Nikov, Andrej, Lesurtel, Mickaël, Keck, Tobias, Kleeff, Jörg, Pandé, Rupaly, Pfeiffer, Per, Pietrasz, D., Roberts, Keith J., Sa Cunha, Antonio, Salvia, Roberto, Strobel, Oliver, Tarvainen, Timo, Bossuyt, Patrick M., van Laarhoven, Hanneke W. M., Wilmink, Johanna W., Groot Koerkamp, Bas, Besselink, Marc G.
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2020
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7489392/
https://ncbi.nlm.nih.gov/pubmed/32910170
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2020.3537
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados